For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function.